27.11.2025 • News

Harbour Group's Americo Acquires Fusion

Harbour Group's Americo has acquired Fusion Chemical, a specialty metalworking fluids manufacturer based in Huntington, Indiana, expanding its product offerings and capacity for growth.

Americo Chemical Products, a Harbour Group company, has acquired Fusion Chemical. 

Fusion, founded in 2012 by Matt East, formulates and manufactures specialty metalworking fluids. These fluids are designed for both high-performance results and low environmental impact and include a full line of next-generation specialty lubricants and coolants used across multiple machining and stamping applications.  The company is based in Huntington, Indiana.

Jeff Fox, Harbour Group's Chairman and Chief Executive, said, "We love partnering with successful founder-owned businesses like Fusion, and we are extremely grateful that Matt placed his trust in us to continue growing his business.  Fusion's people and products are an excellent addition to Americo.  We are confident that the combined business will serve its customers at an even higher level through an expanded product offering." 

"We are very excited to add Fusion's Hybrid-Cool product to our offering – it's a game-changer for the industry," added Chris Bozin, President of Americo.  "We are now able to offer our customers an even more complete and technology-leading product set, one that will ensure their operations run efficiently.  Additionally, we are very fortunate to add Matt and the Fusion team to our company.  Their customer relationships, service, and technical chemistry capabilities are top-notch."

Terms of the transaction were not disclosed.

Company

Logo:

Americo Chemical Products

1765 Holmes Rd
60123 Elgin, IL
US

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read